MARKET

FUSN

Fusion Pharmaceuticals Inc.
FUSN
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-2.0067
832.05
7.56
1,833,042,245.75
*AstraZeneca Announced Acquisition on March 19
Dow Jones · 06/05 04:45
*AstraZeneca Completes Acquisition of Fusion Pharmaceuticals
Dow Jones · 06/05 04:43
Fusion Pharmaceuticals’ Acquisition and Governance Overhaul
TipRanks · 06/04 21:07
ASTRAZENECA BUYS FUSION PHARMA FOR $21 PER SHARE IN CASH
Reuters · 06/04 20:05
*Acquisition Of Fusion Pharmaceuticals Completed FUSN
Dow Jones · 06/04 20:05
Press Release: Acquisition of Fusion Pharmaceuticals Completed
Dow Jones · 06/04 20:05
Weekly Report: what happened at FUSN last week (0527-0531)?
Weekly Report · 06/03 09:26
Ontario court approves AstraZeneca/Fusion acquisition plan
Ontario court approves AstraZeneca/Fusion acquisition plan. The roughly $2B merger is expected to close in Q2. Fusion shareholders approved the deal earlier this week. The company will be acquired by a subsidiary of Astra Zeneca PLC (AZN)
Seeking Alpha · 05/31 22:06
More

Webull offers Fusion Pharmaceuticals Inc. stock information, including NASDAQ: FUSN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FUSN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FUSN stock methods without spending real money on the virtual paper trading platform.